Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 62175-272
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 62175-272). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Oxybutynin 2)
Figure 2 (Oxybutynin 3)
Figure 2 (Oxybutynin 4)
Figure 3 (Oxybutynin 5)
Figure 4 (Oxybutynin 6)
Oxybutynin Chloride Extended Release Tablets 5 mg 100ct Bl Cia72805f Rev. 1019 (Oxybutynin 7)
Oxybutynin Chloride Extended Release Tablets 5 mg 500ct Bl Cia72331g Rev. 1019 (Oxybutynin 8)
Oxybutynin Chloride Extended Release Tablets 10 mg 100ct Bl Cia72806f Rev. 10/19 (Oxybutynin 9)
Oxybutynin Chloride Extended Release Tablets 10 mg 500ct Bl Cia72332g Rev. 10/19 (Oxybutynin 10)
Oxybutynin Chloride Extended Release Tablets 15 mg 100ct Bl Cia72807f Rev. 10/19 (Oxybutynin 11)
Oxybutynin Chloride Extended Release Tablets 15 mg 500ct Bl Cia72333g Rev. 10/19 (Oxybutynin 12)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.